![Albert Edge](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Albert Edge
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Audion Therapeutics BV
![]() Audion Therapeutics BV Pharmaceuticals: MajorHealth Technology Audion Therapeutics BV is a biopharmaceutical firm. It specializes in the discovery, development, and commercialization of drugs and delivery technologies for the treatment of diseases affecting the ear, including hearing loss. The company was founded by Rolf Jan Rutten, Albert Edge, and Helmuth van Es and is headquartered in Amsterdam, the Netherlands.
2
| Holding Company | Pharmaceuticals: Major | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Albert Edge
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Antabio SAS
![]() Antabio SAS Pharmaceuticals: MajorHealth Technology Antabio SAS operates as a biopharmaceutical company which develops drugs for the treatment and prevention of antibiotic-resistant bacterial infections. The firm focuses bacterial disease research, drug design, antibiotic combination testing, and in vitro technology development operations. The company was founded by Marc Lemonnier and Aymeric Dugray on October 15, 2009 and is headquartered in Labege, France. | Pharmaceuticals: Major | Founder | |
GALAPAGOS NV | Biotechnology | Founder | |
Citryll BV
![]() Citryll BV Miscellaneous Commercial ServicesCommercial Services Citryll BV is a private pharmaceutical company located in Oss, the Netherlands, at the Pivot Park. Citryll is dedicated to developing and commercializing therapeutics that target netosis and NETs, with a focus on immune-mediated inflammatory diseases. The Dutch company's lead antibody, Cit-013, has a unique dual mode of action and proprietary NET biomarker assays, making it a promising drug for rheumatoid arthritis and hidradenitis suppurativa. The initial clinical trials with Cit-013 are expected to provide the foundation for a new treatment paradigm for immune-mediated inflammatory diseases. The company was founded in 2015 by Helmuth van Es, Renato Chirivi, and the late Jos Raats of ModiQuest. | Miscellaneous Commercial Services | Chief Executive Officer |
Statistik
International
Niederlande | 3 |
Frankreich | 2 |
Belgien | 2 |
Sektoral
Health Technology | 3 |
Health Services | 2 |
Commercial Services | 2 |
Operativ
Founder | 5 |
Chief Executive Officer | 2 |
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Corporate Officer/Principal | 1 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Helmuth van Es | 5 |
Rolf Jan Rutten | 1 |
- Börse
- Insiders
- Albert Edge
- Unternehmensverbindungen